Navigation Links
CEA in Medical News

Micromet, Inc. Reports Second Quarter 2009 Financial Results

...al product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting cea for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration ...

Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203

...al product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting cea for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration ...

Defeating nicotine's double role in lung cancer

...te for Research, Hospitalization and Health Care (IRCCS), Catholic University, Campus Biomedico University in Rome, Mario Negri Institute in Milan and cea Gyf sur Yvette in France showed in past research that an antagonist of nicotine acetylcholine receptors (nAChRs), may serve as an anticancer agent. Th...

VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque

...linical trials, including without limitation, with respect to the safety and efficacy of VIA-2291; -- if the results of the ACS and cea studies, upon further review and analysis, are revised or negated by authorities or by later stage clinical trials; -- o...

Measles virus may be effective prostate cancer treatment

...an excellent safety record with millions of vaccine doses having been safely administered in over 40 years of use. Repeated measurements of the marker cea (carcinoembryonic antigen, produced when the virus replicates) following MV-CEA treatment can be performed via a simple blood test, and can potentiall...

AdvaMed 2008 Sponsor Participation Increases by 52%

...nt Track) -- Powell Goldstein LLP (Emerging Company Issues Track) -- REED Exhibitions (Global Business Issues Track) Collateral Sponsors: -- cea Technologies -- Ernst & Young -- Georgia Hidden List Department of Economic Development -- Korn/Ferry International -- MedNet Solut...

Micromet, Inc. Reports Second Quarter 2008 Financial Results

..., Inc. and is being developed in a phase 1 clinical trial for the treatment of patients with cancer. Three additional BiTE antibodies, targeting CD33, cea and MCSP, respectively, are in preclinical development. In addition, Micromet has established a collaboration with Nycomed for the development and com...

FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer

...et that the FDA has granted for any monitoring product for CRC since January 14, 1982 when Carcinoembryonic Antigen (CEA) was approved. Until now, the cea test has been the only accepted method cleared in the U.S. DR-70 (FDP) offers a new test that can monitor CRC tumors post-surgery. The DR-70 (FDP) t...

Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals

...y determination services to America's hospitals. cea guides uninsured patients through complex applicat...Led by Ulrich and his exceptional management team, cea provides tremendous value to its hospital customer...s across the country. We are quite excited to help cea continue its impressive growth, and we look forwar...

Partnerships Effective Communicators of Cancer Advances

...planning. Nearly all the patients (93 percent) received appropriate surveillance with history and physical exams at suggested intervals and routine cea testing. Abdominal and pelvic surveillance CT was performed in 78 percent of patients. "We found a drop-off in compliance (49 percent) regarding th...

Partnership of academic centers and community hospitals effective model for disseminating advances

...eport (91 percent), colonoscopy (75 percent and 58 percent reaching cecum), cea (91 percent), CT abdomen/pelvis (93 percent), and chest imaging (100 percen...eillance with history and physical exams at suggested intervals and routine cea testing. Abdominal and pelvic surveillance CT was performed in 78 percent o...

Vascular surgeons ask, what's next for carotid artery stenting?

... of Vascular Surgery. "Currently, the choice of cea versus CAS in individual patients is based more on... has now been fairly well established that CAS and cea yield comparable results in "high-risk" patients. ...isk" patients. Some studies suggest that CAS and cea produce similar results, but others have found a l...

Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients

...cromet's proprietary BiTE product development platform. In addition to current studies of MT103, three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. BiTE is a registered trademark of Micromet. About MT103 MT103, which is being co-developed with MedIm...

Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action

...oof-of-concept in an ongoing phase 1 clinical study in advanced non-Hodgkin's lymphoma patients. Three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. About Micromet, Inc. (http://www.micromet-inc.com ) Micromet, Inc. is a biopharmaceutical company develo...

Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia

...oof-of-concept in an ongoing phase 1 clinical study in advanced non-Hodgkin's lymphoma patients. Three other BiTE antibodies, targeting EpCAM (CD326), cea and MCSP, are in pre-clinical development. About MT103 (MEDI-538) MT103, which is being co-developed with MedImmune as MEDI-538, is a BiTE(R) antibo...

18F-DG PET/CT can highly increase the detection of colorectal cancer

...2006. After PET/CT imaging, recurrence and/or metastasis were confirmed in 82.4% (56/68) of the patients, with 91.7% (22/24) cases with elevated serum cea levels. PET/CT detected more lesions than CT or ultrasonography alone in 30.4 % (17/56) of the cases of recurrence and/or metastasis. CRC is the m...
Other Tags
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
(Date:7/31/2015)... China , 31 de julio de 2015 ... www.icg-10.org ) se celebrará por medio de BGI del 22 al ... . Este año, la conferencia celebra ... ICG se ha convertido en una de las reuniones anuales ... ser una de las reuniones más dinámicas, entusiastas y mejores ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly ... for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, ... delete any message including ones already sent. , While text messaging has more features ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the STASH awards ... awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, featured in ... products that have stood the test of time. These include lighting products, organic ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
(Date:7/31/2015)... CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will ... National Football League’s biggest day each year is the Super Bowl. In the two weeks ... takes place from the host venue. The 2016 Super Bowl game will mark the 50th ...
(Date:7/31/2015)... ... 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle ... provider of Exilis non-surgical fat reduction in New York. Due to its unparalleled ... International clientele. Many patients travel to New York to get their non-surgical skin ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
Other Contents